Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2315 stock hub

HKG/2315 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2315is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

42.7B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2315

In the news

Latest news · HKG/2315

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E59.6

P25 11.7P50 18.9P75 41.4

Trailing P/E63.2

P25 10.7P50 17.9P75 38.5

ROE18.6

P25 -14.7P50 2P75 9.4

ROIC19.7

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2315 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

CNY

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	1,443
Employees Change	326%
Employees Change Percent	29.19
Enterprise value	HKD 42.4B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100005D27
Last refreshed	2026-05-10
Market cap	HKD 42.7B
Price	HKD 51.45
Price currency	HKD
Rev Per Employee	1,230,819.13x
Sector	Healthcare
Sic	2836
Symbol	hkg/2315
Website	https://biocytogen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.77%
EV Earnings	128.38x
EV/EBIT	111.59x
EV/EBITDA	80.08x
EV/FCF	124.92x
EV/Sales	23.87x
FCF yield	0.8%
Forward P/E	59.59x
P/B ratio	16.41x
P/E ratio	63.19x
P/S ratio	24.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.39%
EBITDA Margin	28.01%
FCF margin	19.1%
Gross margin	76.18%
Gross Profit	HKD 1.4B
Gross Profit Growth	52.41%
Gross Profit Growth Q	5.27%
Gross Profit Growth3 Y	40.93%
Net Income	HKD 330.2M
Net Income Growth	536.56%
Net Income Growth Q	-23.4%
Net Income Growth Quarters	6%
Net Income Growth Years	3%
Pretax Margin	19.52%
Profit Margin	18.59%
Profit Per Employee	HKD 228,815
Profitable Years	2
Roa5y	-5.62
ROCE	11.15
ROE	18.59
Roe5y	-22.85
ROIC	19.72
Roic5y	-30.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	328.46%
Cagr3y	27.36%
EPS Growth	575.2
EPS Growth Q	-18.32
EPS Growth Quarters	6
EPS Growth Years	3
FCF Growth	54.45%
FCF Growth Q	-62.51%
OCF Growth	108.75%
OCF Growth Q	30.47%
Revenue Growth	52.51x
Revenue Growth Q	10.88x
Revenue Growth Quarters	6x
Revenue Growth Years	5x
Revenue Growth3 Y	38.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	HKD 4.2B
Cash	HKD 1.4B
Current Assets	HKD 2.1B
Current Liabilities	HKD 782M
Debt	HKD 1.1B
Debt EBITDA	HKD 2.13
Debt Equity	HKD 0.43
Debt FCF	HKD 3.33
Equity	HKD 2.6B
Interest Coverage	4.78
Liabilities	HKD 1.6B
Long Term Assets	HKD 2.1B
Long Term Liabilities	HKD 798.3M
Net Cash	HKD 269.8M
Net Cash By Market Cap	HKD 0.63
Net Debt EBITDA	HKD -0.54
Net Debt Equity	HKD -0.1
Net Debt FCF	HKD -0.8
Tangible Book Value	HKD 2.5B
Tangible Book Value Per Share	HKD 5.67
WACC	5.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.7
Net Working Capital	HKD 327.9M
Quick ratio	2.29
Working Capital	HKD 1.3B
Working Capital Turnover	HKD 2.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	5.72%
Payout Ratio	5.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	328.04%
200-day SMA	36.74
3Y total return	106.63%
50-day SMA	55.01
50-day SMA vs 200-day SMA	50over200
All Time High	70.15
All Time High Change	-26.66%
All Time High Date	2026-04-08
All Time Low	5.6
All Time Low Change	818.75%
All Time Low Date	2024-11-14
ATR	4.42
Beta	0.13
Beta1y	-0.07
Beta2y	0.2
Ch YTD	45.75
High	52.3
High52	70.15
High52 Date	2026-04-08
High52ch	-26.66%
Low	50.5
Low52	11.6
Low52 Date	2025-05-14
Low52ch	343.53%
Ma50ch	-6.48%
Price vs 200-day SMA	40.06%
RSI	44.11
RSI Monthly	77.45
RSI Weekly	59.32
Sharpe ratio	2.08x
Sortino ratio	3.92
Total Return	5.72%
Tr YTD	45.75
Tr1m	-18.98%
Tr1w	-2.56%
Tr3m	7.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 379.8M
Operating Income Growth	141.4
Operating Income Growth Q	-7.44
Operating margin	21.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	158,020,256%
Net Borrowing	-190,060,168.3
Shares Insiders	14.07%
Shares Institutions	30.27%
Shares Out	446,898,420
Shares Qo Q	7.03%
Shares Yo Y	-5.72%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 299.3M
Average Volume	1,302,699.9x
Bv Per Share	5.8
CAPEX	HKD -207.6M
Ch1m	-18.98
Ch1w	-2.56
Ch1y	328
Ch3m	7.86
Ch3y	106.6
Ch6m	83.75
Change	-3.02%
Change From Open	-1.06
Close	53.05
Days Gap	-1.98
Depreciation Amortization	119,137,909.2
Dollar Volume	18,161,850
Earnings Date	2026-04-27
EBIT	HKD 379.8M
EBITDA	HKD 497.4M
EPS	HKD 0.81
F Score	3
FCF	HKD 339.3M
FCF EV Yield	0.8x
FCF Per Share	HKD 0.76
Financing CF	772,511,368
Fiscal Year End	December
Founded	2,008
Graham Number	10.31157
Graham Upside	-79.96
Income Tax	HKD 16.5M
Investing CF	-777,634,145
Is Primary Listing	1
Last Earnings Date	2026-04-27
Last Report Date	2026-03-31
Ma150	40.96
Ma150ch	25.61%
Ma20	56
Ma20ch	-8.12%
Net CF	536,467,321
Next Earnings Date	2026-05-28
Open	52
P FCF Ratio	125.7
P OCF Ratio	77.99
Position In Range	52.78
Ppne	1,706,077,841.2
Price Date	2026-05-08
Price EBITDA	HKD 85.74
Ptbv Ratio	16.82
Relative Volume	0.26x
Revenue	1,776,072,003x
SBC By Revenue	2.26x
Share Based Comp	40,055,210
Tax By Revenue	0.93x
Tax Rate	4.76%
Tr6m	83.75%
Volume	353,000
Z Score	6.59

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2315 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/2315 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/2315?

Insider, institutional, and short-interest positioning.

Institutional ownership

+30.3%

Share of float held by funds and institutions

Insider ownership

+14.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-5.7%

Negative means the company is buying back shares.

Technical

HKG/2315 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.1

Neutral momentum band

Price vs 200-day MA

+40.1%

50/200-day relationship not available

Beta (5Y)

0.13

Less volatile than the market

Sharpe ratio

2.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2315

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2315 stock rating?

hkg/2315 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2315 analysis?

The full report lives at /stocks/hkg/2315/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2315?

The latest report frames hkg/2315 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2315 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.